CASP1 and inflammatory response: More importantly, we have demonstrated in animal experiments that the protective effect of IAld on intestinal inflammation is associated with the NLRP3 inflammasome, as IAld treatment significantly reduced the LPS-induced expression level of the caspase-1 protein, an NLRP3 inflammasome effector.